Literature DB >> 26369925

Growth hormone therapy in children with CKD after more than two decades of practice.

Lesley Rees1.   

Abstract

This review focuses on the evidence for the efficacy and safety of recombinant human growth hormone (rhGH) therapy in children with all stages of chronic kidney disease (CKD) and at all ages. It describes the improving height prognosis for our patients both with and without rhGH; explains the underlying hormonal abnormalities that provide the rationale for rhGH use in CKD and the endocrine changes that accompany treatment; and views on who warrants treatment, with what dose, and how long for.

Entities:  

Keywords:  Final height; Growth; Growth hormone

Mesh：

Substances：

Year:  2015        PMID： 26369925     DOI： 10.1007/s00467-015-3179-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  85 in total

1.  Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry.

Authors:  Richard N Fine; Donald Stablein
Journal:  Pediatr Nephrol       Date:  2005-01-29       Impact factor: 3.714

Review 2.  Nutrition and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

3.  Kidney transplanted children come of age.

Authors:  G Offner; K Latta; P F Hoyer; H J Baum; J H Ehrich; R Pichlmayr; J Brodehl
Journal:  Kidney Int       Date:  1999-04       Impact factor: 10.612

4.  Normal adult height after steroid-withdrawal within 6 months of pediatric kidney transplantation: a 20 years single center experience.

Authors:  Bernd Klare; Carmen R Montoya; Dagmar-C Fischer; Manfred J Stangl; Dieter Haffner
Journal:  Transpl Int       Date:  2011-12-21       Impact factor: 3.782

5.  Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.

Authors:  A Hokken-Koelega; P Mulder; R De Jong; M Lilien; R Donckerwolcke; J Groothof
Journal:  Pediatr Nephrol       Date:  2000-07       Impact factor: 3.714

Review 6.  Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review.

Authors:  Annalisa Deodati; Stefano Cianfarani
Journal:  BMJ       Date:  2011-03-11

Review 7.  Growth hormone/insulin-like growth factor system in children with chronic renal failure.

Authors:  Burkhard Tönshoff; Daniela Kiepe; Sonia Ciarmatori
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

8.  Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology.

Authors:  Etienne Bérard; Jean Luc André; Geneviève Guest; Frédéric Berthier; Mickael Afanetti; Pierre Cochat; Michel Broyer
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

9.  Differential effects of short-term growth hormone therapy on the cardiovascular risk profile in patients with chronic kidney disease: a pilot study.

Authors:  D-C Fischer; R Nissel; A Puhlmann; A Mitzner; M Tiess; R Schmidt; D Haffner
Journal:  Clin Nephrol       Date:  2009-11       Impact factor: 0.975

10.  Short-term growth hormone treatment and microcirculation: effects in patients with chronic kidney disease.

Authors:  Richard Nissel; Dagmar-Christiane Fischer; Andreas Puhlmann; Birgit Holdt-Lehmann; Andrea Mitzner; Michael Petzsch; Thomas Körber; Michael Tiess; Reinhard Schmidt; Dieter Haffner
Journal:  Microvasc Res       Date:  2009-06-03       Impact factor: 3.514
View more
  11 in total

1.  Short stature in advanced pediatric CKD is associated with faster time to reduced kidney function after transplant.

Authors:  Yijun Li; Larry A Greenbaum; Bradley A Warady; Susan L Furth; Derek K Ng
Journal:  Pediatr Nephrol       Date:  2019-01-09       Impact factor: 3.714

2.  Treatment of Growth Retardation in a Child with CKD.

Authors:  Emily Stonebrook; John D Mahan
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-26       Impact factor: 8.237

3.  Growth hormone therapy for a patient with idiopathic Fanconi syndrome and growth hormone deficiency.

Authors:  Takayuki Okamoto; Yasuyuki Sato; Takeshi Yamazaki; Asako Hayashi; Toshiyuki Takahashi
Journal:  CEN Case Rep       Date:  2017-02-09

4.  Effectiveness of growth hormone on growth and final height in paediatric chronic kidney disease.

Authors:  Melanie K Aldridge; Peter Trnka; Anna Francis; Steven J McTaggart
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.714

5.  Growth hormone therapy in pediatric kidney transplantation-the long-term clinical benefits beyond improvement of growth after withdrawal of pre-transplant therapy.

Authors:  Ryszard Grenda
Journal:  Pediatr Nephrol       Date:  2021-09-20       Impact factor: 3.651

Review 6.  Pubertal development in children with chronic kidney disease.

Authors:  Dieter Haffner; Miroslav Zivicnjak
Journal:  Pediatr Nephrol       Date:  2016-07-27       Impact factor: 3.714

7.  Chronic kidney disease in children.

Authors:  Francesca Becherucci; Rosa Maria Roperto; Marco Materassi; Paola Romagnani
Journal:  Clin Kidney J       Date:  2016-06-05

8.  Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report.

Authors:  Oleh M Akchurin; Amy J Kogon; Juhi Kumar; Christine B Sethna; Hoda T Hammad; Paul J Christos; John D Mahan; Larry A Greenbaum; Robert Woroniecki
Journal:  BMC Nephrol       Date:  2017-05-30       Impact factor: 2.388

Review 9.  Growth and Nutrition in Pediatric Chronic Kidney Disease.

Authors:  Douglas M Silverstein
Journal:  Front Pediatr       Date:  2018-08-14       Impact factor: 3.418

10.  Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone.

Authors:  Marco Cappa; Mohamad Maghnie; Vincenza Carbone; Laura Chioma; Carmela Errichiello; Claudia Giavoli; Mario Giordano; Laura Guazzarotti; Antonella Klain; Giovanni Montini; Luisa Murer; Maria Parpagnoli; Carmine Pecoraro; Sabino Pesce; Enrico Verrina
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.